JADE BIOSCIENCES INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$14.06
-1.26%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+2.1%
3 months
-26.6%
6 months
-42.0%
1 year
+42.7%
Year to date
-8.9%
52-week range
$8.95 – $26.85
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$894.2M
P/E
-5.8
P/B
2
P/S
—
Revenue
$0
Net income
-$153.24M
Diluted EPS
-1.92
Gross margin
—
Net margin
—
Return on equity
-49.10%
Total debt
$628K
Cash
$107.25M
Free cash flow
-$123.57M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$55.77M | — | — | -$43.66M |
| Mar 31, 2026 | $0 | -$40.37M | — | — | -$24.08M |
| Dec 31, 2025 | $0 | -$31.93M | — | — | -$33.65M |
| Sep 30, 2025 | $0 | -$25.18M | — | — | -$22.18M |
| Jun 30, 2025 | $0 | -$32.13M | — | — | -$36.67M |
| Mar 31, 2025 | $0 | -$2.52M | — | — | -$2.38M |
| Dec 31, 2024 | $0 | -$5.43M | — | — | -$11.05M |
| Sep 30, 2024 | $0 | -$16.24M | — | — | -$16.04M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent JBIO news
All market newsNo ticker-linked stories are in the current archive.